Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 26.81
-0.05 (-0.19%)
At close: Feb 13, 2026
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.4 billion as of February 13, 2026. Its market cap has increased by 227.18% in one year.
Market Cap
5.40B
Enterprise Value
5.23B
Revenue
1.67B
Ranking
n/a
PE Ratio
22.48
Stock Price
26.81
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.40B, a decrease of -20.93%. That is a compound annual growth rate of -4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.40B | 29.33% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kexing Biopharm | 6.05B |
| Lifecome Biochemistry | 5.80B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.73B |
| Jiangsu Bioperfectus Technologies | 5.67B |
| ChemPartner PharmaTech | 5.53B |
| Hangzhou Biotest Biotech | 5.49B |
| Beijing Bohui Innovation Biotechnology Group | 5.12B |
| Assure Tech (Hangzhou) | 5.00B |